Cas:104481-67-6 1-[(2,5-dimethylphenyl)methyl]piperazine manufacturer & supplier

Chemical Name:1-[(2,5-dimethylphenyl)methyl]piperazine

CAS.NO:104481-67-6

Synonyms:1-[(2,5-dimethylphenyl)methyl]piperazine

Molecular Formula:C₁₃H₂₀N₂

Molecular Weight:204.31100

HS Code:2933599090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:15.27000

Exact Mass:204.16300

LogP:1.97530

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-[(2,5-dimethylphenyl)methyl]piperazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-[(2,5-dimethylphenyl)methyl]piperazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-[(2,5-dimethylphenyl)methyl]piperazine Use and application,1-[(2,5-dimethylphenyl)methyl]piperazine technical grade,usp/ep/jp grade.

Related News: ��Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations�� (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials. 1-[(2,5-dimethylphenyl)methyl]piperazine manufacturer The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application. 1-[(2,5-dimethylphenyl)methyl]piperazine supplier It’s the first confirmed Wuhan coronavirus death from outside of mainland China, and brings the total toll to 305. 1-[(2,5-dimethylphenyl)methyl]piperazine vendor It found that about 5% of both groups of women have a genetic mutation that increases the risk of breast cancer. 1-[(2,5-dimethylphenyl)methyl]piperazine factory ��Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations�� (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials.